TACROLIMUS

TACROLIMUS was reported 159808 times

TACROLIMUS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROPHYLAXIS AGAINST TRANSPLANT REJECTION 103 1.0000
1 NEW ONSET DIABETES AFTER TRANSPLANTATION 168 0.9711
2 TRANSPLANTATION ASSOCIATED FOOD ALLERGY 96 0.9505
3 MALACOPLAKIA 404 0.8821
4 RENAL GRAFT INFECTION 197 0.8491
5 POST TRANSPLANT DISTAL LIMB SYNDROME 167 0.8227
6 TRICHODYSPLASIA SPINULOSA 310 0.8136
7 SMOOTH MUSCLE CELL NEOPLASM 339 0.8110
8 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 1861 0.7936
9 PHAEOHYPHOMYCOSIS 376 0.7850
10 DELAYED GRAFT FUNCTION 546 0.7679
11 PANCREAS TRANSPLANT REJECTION 149 0.7413
12 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 2437 0.7371
13 TRANSPLANT DYSFUNCTION 1279 0.7161
14 CHRONIC ALLOGRAFT NEPHROPATHY 544 0.6948
15 POLYOMAVIRUS VIRAEMIA 737 0.6940
16 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 806 0.6717
17 DONOR SPECIFIC ANTIBODY PRESENT 102 0.6623
18 ALTERNARIA INFECTION 243 0.6532
19 RHODOCOCCUS INFECTION 108 0.6506
20 TRANSPLANT REJECTION 5112 0.6375
21 LIVER TRANSPLANT REJECTION 1108 0.6162
22 RENAL TRANSPLANT FAILURE 607 0.6144
23 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 3126 0.6135
24 PARVOVIRUS B19 INFECTION 543 0.6067
25 COMPLICATIONS OF TRANSPLANTED KIDNEY 1377 0.6066
26 HEART TRANSPLANT REJECTION 623 0.6002
27 HUMAN POLYOMAVIRUS INFECTION 312 0.5876
28 LUNG TRANSPLANT REJECTION 368 0.5576
29 HUMAN HERPESVIRUS 8 INFECTION 332 0.5452
30 CEREBRAL NOCARDIOSIS 124 0.5322
31 PULMONARY NOCARDIOSIS 435 0.5279
32 ACANTHAMOEBA INFECTION 96 0.5106
33 GRAFT LOSS 357 0.4924
34 COMPLICATIONS OF TRANSPLANTED LUNG 151 0.4919
35 KIDNEY TRANSPLANT REJECTION 2343 0.4878
36 BK VIRUS INFECTION 1584 0.4692
37 PULMONARY MUCORMYCOSIS 247 0.4678
38 COMPLICATIONS OF TRANSPLANTED HEART 100 0.4651
39 DISSEMINATED MUCORMYCOSIS 183 0.4645
40 HUMAN EHRLICHIOSIS 97 0.4641
41 EPSTEIN-BARR VIRAEMIA 509 0.4590
42 BLASTOMYCOSIS 216 0.4444
43 CYTOMEGALOVIRUS VIRAEMIA 1933 0.4341
44 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 104 0.4245
45 CRYPTOSPORIDIOSIS INFECTION 222 0.4229
46 COMPLICATIONS OF TRANSPLANTED LIVER 150 0.4167
47 MONKEYPOX 115 0.4167
48 SCEDOSPORIUM INFECTION 288 0.4079
49 NOCARDIOSIS 1001 0.3910
50 MICROSPORIDIA INFECTION 136 0.3875
51 DERMATOPHYTOSIS 110 0.3873
52 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 356 0.3844
53 HEPATIC ARTERY THROMBOSIS 112 0.3823
54 TRANSPLANT FAILURE 909 0.3704
55 HUMAN HERPESVIRUS 6 ENCEPHALITIS 101 0.3556
56 RENAL TUBULAR ATROPHY 313 0.3549
57 VIRAL HAEMORRHAGIC CYSTITIS 252 0.3539
58 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 977 0.3531
59 MYCOBACTERIUM HAEMOPHILUM INFECTION 100 0.3497
60 WEST NILE VIRAL INFECTION 262 0.3493
61 CYTOMEGALOVIRUS ENTERITIS 124 0.3483
62 GRAFT VERSUS HOST DISEASE IN SKIN 764 0.3465
63 ACUTE GRAFT VERSUS HOST DISEASE 1582 0.3453
64 GRAFT VERSUS HOST DISEASE IN LUNG 165 0.3452
65 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 102 0.3423
66 CYSTITIS VIRAL 131 0.3420
67 CHRONIC GRAFT VERSUS HOST DISEASE 1206 0.3337
68 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 121 0.3324
69 IDIOPATHIC PNEUMONIA SYNDROME 99 0.3322
70 ADENOVIRUS INFECTION 956 0.3293
71 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 701 0.3291
72 UREAPLASMA INFECTION 133 0.3260
73 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 459 0.3248
74 DISSEMINATED CRYPTOCOCCOSIS 242 0.3197
75 RENAL TUBULAR INJURY 386 0.3177
76 MUCORMYCOSIS 821 0.3156
77 LYMPHOCELE 209 0.3148
78 CAT SCRATCH DISEASE 126 0.3134
79 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 499 0.3113
80 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 222 0.3088
81 INFECTION REACTIVATION 352 0.3074
82 THROMBOTIC MICROANGIOPATHY 2989 0.3064
83 ALVEOLAR PROTEINOSIS 180 0.3041
84 CRYPTOCOCCOSIS 485 0.2974
85 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 387 0.2938
86 CYTOMEGALOVIRUS OESOPHAGITIS 107 0.2908
87 KIDNEY FIBROSIS 501 0.2886
88 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 507 0.2866
89 CYTOMEGALOVIRUS INFECTION 4728 0.2842
90 CYTOMEGALOVIRUS INFECTION REACTIVATION 1249 0.2825
91 EPSTEIN-BARR VIRUS INFECTION 1705 0.2726
92 GRAFT VERSUS HOST DISEASE IN LIVER 195 0.2723
93 SYSTEMIC MYCOSIS 315 0.2697
94 ENGRAFTMENT SYNDROME 158 0.2673
95 HEPATITIS E 419 0.2652
96 GRAFT VERSUS HOST DISEASE 1855 0.2577
97 COMPLICATIONS OF TRANSPLANT SURGERY 130 0.2574
98 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 206 0.2534
99 STRONGYLOIDIASIS 407 0.2517
100 HISTOPLASMOSIS DISSEMINATED 396 0.2494
101 GRAFT COMPLICATION 144 0.2453
102 VIRAEMIA 338 0.2439
103 STENOTROPHOMONAS INFECTION 329 0.2424
104 MENINGITIS CRYPTOCOCCAL 422 0.2411
105 TOXOPLASMOSIS 260 0.2407
106 PNEUMONIA CYTOMEGALOVIRAL 465 0.2392
107 CYTOMEGALOVIRUS COLITIS 548 0.2381
108 CEREBRAL ASPERGILLOSIS 146 0.2374
109 JC VIRUS INFECTION 377 0.2356
110 CYTOMEGALOVIRUS TEST POSITIVE 404 0.2265
111 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 116 0.2214
112 INFECTIVE ANEURYSM 109 0.2202
113 DISSEMINATED ASPERGILLOSIS 103 0.2182
114 GLOMERULOSCLEROSIS 137 0.2168
115 MYCOBACTERIUM ABSCESSUS INFECTION 154 0.2154
116 ANGIOSARCOMA 99 0.2148
117 CORYNEBACTERIUM INFECTION 114 0.2131
118 LOCKED-IN SYNDROME 98 0.2126
119 ASPERGILLUS INFECTION 1392 0.2119
120 PNEUMONIA CRYPTOCOCCAL 199 0.2106
121 HUMAN HERPESVIRUS 6 INFECTION 393 0.2077
122 DRUG LEVEL FLUCTUATING 184 0.2072
123 PNEUMOCYSTIS JIROVECII INFECTION 245 0.2050
124 BRAIN ABSCESS 519 0.2049
125 KLEBSIELLA INFECTION 1034 0.2043
126 ENTEROCOCCAL INFECTION 984 0.2034
127 EPSTEIN-BARR VIRUS TEST POSITIVE 127 0.2013
128 KLEBSIELLA BACTERAEMIA 189 0.1989
129 INFECTION IN AN IMMUNOCOMPROMISED HOST 142 0.1978
130 VARICELLA ZOSTER VIRUS INFECTION 407 0.1961
131 URETERIC STENOSIS 156 0.1948
132 CEREBRAL TOXOPLASMOSIS 180 0.1927
133 OSMOTIC DEMYELINATION SYNDROME 142 0.1924
134 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 148 0.1878
135 BRONCHOPULMONARY ASPERGILLOSIS 1420 0.1830
136 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 108 0.1827
137 FUSARIUM INFECTION 127 0.1814
138 MYCOPLASMA INFECTION 139 0.1780
139 CYTOMEGALOVIRUS ENTEROCOLITIS 133 0.1727
140 ACINETOBACTER INFECTION 188 0.1717
141 OBLITERATIVE BRONCHIOLITIS 225 0.1714
142 VISCERAL LEISHMANIASIS 121 0.1676
143 ENTEROBACTER INFECTION 275 0.1635
144 ENCEPHALITIS VIRAL 199 0.1634
145 ENTEROCOCCAL SEPSIS 131 0.1617
146 SECONDARY IMMUNODEFICIENCY 191 0.1572
147 GASTROENTERITIS NOROVIRUS 207 0.1558
148 HISTOPLASMOSIS 275 0.1552
149 PNEUMONIA PSEUDOMONAL 231 0.1505
150 ENTEROVIRUS INFECTION 130 0.1505
151 PNEUMATOSIS INTESTINALIS 428 0.1499
152 HAEMOLYTIC URAEMIC SYNDROME 346 0.1491
153 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1410 0.1476
154 ENTEROCOCCAL BACTERAEMIA 152 0.1434
155 MYCOBACTERIAL INFECTION 246 0.1427
156 RENAL TRANSPLANT 512 0.1416
157 APLASIA PURE RED CELL 485 0.1408
158 NOROVIRUS INFECTION 200 0.1385
159 VENOOCCLUSIVE LIVER DISEASE 671 0.1357
160 IGA NEPHROPATHY 223 0.1343
161 CYSTITIS HAEMORRHAGIC 541 0.1341
162 PROTEUS INFECTION 96 0.1337
163 PNEUMONIA KLEBSIELLA 243 0.1321
164 NEPHROPATHY TOXIC 1467 0.1306
165 PNEUMOCYSTIS JIROVECII PNEUMONIA 1298 0.1291
166 HERPES ZOSTER DISSEMINATED 103 0.1283
167 ACTINIC KERATOSIS 332 0.1278
168 RENAL ARTERY STENOSIS 173 0.1255
169 PSEUDOMONAS INFECTION 1076 0.1253
170 SUPERINFECTION BACTERIAL 99 0.1248
171 CYTOMEGALOVIRUS CHORIORETINITIS 242 0.1240
172 URINARY TRACT INFECTION ENTEROCOCCAL 115 0.1231
173 BILE DUCT STENOSIS 147 0.1226
174 ANOGENITAL WARTS 109 0.1222
175 LYMPHOPROLIFERATIVE DISORDER 357 0.1214
176 ESCHERICHIA INFECTION 983 0.1194
177 ASPERGILLOSIS 156 0.1194
178 ACUTE MYELOID LEUKAEMIA RECURRENT 249 0.1159
179 FUNGAL SEPSIS 96 0.1155
180 SYSTEMIC CANDIDA 288 0.1146
181 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 841 0.1120
182 GLOMERULONEPHRITIS MEMBRANOUS 131 0.1114
183 DRUG LEVEL INCREASED 1844 0.1113
184 VACCINATION FAILURE 184 0.1106
185 ATYPICAL MYCOBACTERIAL INFECTION 156 0.1102
186 KLEBSIELLA SEPSIS 124 0.1100
187 INFECTIOUS PLEURAL EFFUSION 167 0.1097
188 GINGIVAL HYPERTROPHY 163 0.1074
189 LUPUS NEPHRITIS 200 0.1068
190 DIFFUSE LARGE B-CELL LYMPHOMA 823 0.1067
191 RENAL TUBULAR ACIDOSIS 233 0.1067
192 GLOMERULONEPHRITIS 260 0.1061
193 CENTRAL NERVOUS SYSTEM INFECTION 121 0.1056
194 HYPERTROPHIC CARDIOMYOPATHY 163 0.1052
195 ESCHERICHIA BACTERAEMIA 247 0.1050
196 PAPILLOMA VIRAL INFECTION 173 0.1048
197 TRANSITIONAL CELL CARCINOMA 136 0.1048
198 ILEAL ULCER 106 0.1047
199 NEUROENDOCRINE CARCINOMA OF THE SKIN 101 0.1032
200 PYELONEPHRITIS ACUTE 200 0.1019
201 PNEUMONIA FUNGAL 400 0.1013
202 PNEUMOMEDIASTINUM 178 0.0984
203 CENTRAL NERVOUS SYSTEM LYMPHOMA 135 0.0979
204 STEROID DIABETES 146 0.0973
205 SQUAMOUS CELL CARCINOMA OF SKIN 587 0.0971
206 DIFFUSE ALVEOLAR DAMAGE 109 0.0948
207 VENOOCCLUSIVE DISEASE 236 0.0942
208 BACTERIAL SEPSIS 303 0.0929
209 RENAL TUBULAR NECROSIS 902 0.0919
210 PARAINFLUENZAE VIRUS INFECTION 139 0.0913
211 DISSEMINATED TUBERCULOSIS 230 0.0896
212 HISTIOCYTOSIS HAEMATOPHAGIC 266 0.0895
213 FUNGAEMIA 139 0.0883
214 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2451 0.0864
215 HYPOGAMMAGLOBULINAEMIA 567 0.0862
216 URINARY TRACT INFECTION BACTERIAL 213 0.0842
217 FUNGAL SKIN INFECTION 333 0.0824
218 DRUG LEVEL ABOVE THERAPEUTIC 367 0.0800
219 BACTERAEMIA 939 0.0790
220 HERPES SIMPLEX 514 0.0790
221 ESCHERICHIA URINARY TRACT INFECTION 335 0.0787
222 LIVER TRANSPLANT 286 0.0786
223 NORMOCYTIC ANAEMIA 115 0.0782
224 OPPORTUNISTIC INFECTION 143 0.0773
225 MYCOBACTERIUM AVIUM COMPLEX INFECTION 206 0.0767
226 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 201 0.0755
227 ORGANISING PNEUMONIA 368 0.0742
228 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 145 0.0734
229 STAPHYLOCOCCAL BACTERAEMIA 310 0.0712
230 LOW BIRTH WEIGHT BABY 558 0.0702
231 PYELONEPHRITIS 608 0.0701
232 LUNG CONSOLIDATION 194 0.0693
233 PNEUMOPERITONEUM 128 0.0692
234 PNEUMONIA PNEUMOCOCCAL 102 0.0688
235 ACUTE RESPIRATORY DISTRESS SYNDROME 1191 0.0673
236 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 554 0.0671
237 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 332 0.0666
238 AUTOIMMUNE HAEMOLYTIC ANAEMIA 228 0.0665
239 PNEUMOCYSTIS JIROVECI PNEUMONIA 148 0.0664
240 PNEUMONIA STAPHYLOCOCCAL 131 0.0663
241 HYPERPARATHYROIDISM SECONDARY 165 0.0658
242 ESCHERICHIA SEPSIS 190 0.0655
243 PSEUDOMONAL SEPSIS 114 0.0650
244 LIVER ABSCESS 211 0.0650
245 HYDRONEPHROSIS 481 0.0642
246 NEPHROTIC SYNDROME 440 0.0641
247 OPTIC NEUROPATHY 135 0.0637
248 VASCULAR PSEUDOANEURYSM 111 0.0637
249 COVID-19 PNEUMONIA 742 0.0628
250 SOFT TISSUE INFECTION 115 0.0628
251 RHINOVIRUS INFECTION 242 0.0621
252 PNEUMONIA BACTERIAL 568 0.0618
253 RENAL TUBULAR DISORDER 173 0.0614
254 SEPTIC SHOCK 2658 0.0610
255 HAEMATOLOGICAL INFECTION 144 0.0588
256 HEPATIC FIBROSIS 202 0.0588
257 EMPYEMA 113 0.0568
258 NEUROTOXICITY 994 0.0567
259 VARICELLA 135 0.0565
260 ENCEPHALITIS 387 0.0559
261 SQUAMOUS CELL CARCINOMA 522 0.0554
262 PATHOGEN RESISTANCE 505 0.0553
263 LARGE INTESTINAL ULCER 150 0.0552
264 CHOLANGITIS 342 0.0551
265 BLOOD CREATININE ABNORMAL 190 0.0549
266 OESOPHAGEAL CANDIDIASIS 216 0.0541
267 PRE-ECLAMPSIA 255 0.0536
268 STAPHYLOCOCCAL SEPSIS 263 0.0532
269 CANDIDA INFECTION 896 0.0530
270 CLOSTRIDIUM DIFFICILE COLITIS 558 0.0526
271 APLASTIC ANAEMIA 269 0.0515
272 SHOCK HAEMORRHAGIC 419 0.0514
273 ABDOMINAL INFECTION 131 0.0512
274 PROTEINURIA 972 0.0511
275 THROMBOTIC THROMBOCYTOPENIC PURPURA 180 0.0510
276 LUNG ABSCESS 106 0.0505
277 PULMONARY ALVEOLAR HAEMORRHAGE 283 0.0504
278 BRAIN HERNIATION 150 0.0502
279 OESOPHAGEAL ULCER 193 0.0501
280 OLIGURIA 311 0.0500
281 HEPATITIS C 600 0.0496
282 LEUKOENCEPHALOPATHY 185 0.0496
283 OESOPHAGEAL STENOSIS 141 0.0495
284 GRANULOMA 168 0.0485
285 DRUG LEVEL DECREASED 493 0.0484
286 SCLERODERMA 176 0.0484
287 HEPATOSPLENOMEGALY 124 0.0483
288 HEPATIC NECROSIS 181 0.0480
289 NEPHROGENIC SYSTEMIC FIBROSIS 145 0.0479
290 UROSEPSIS 438 0.0474
291 OVARIAN CYST 472 0.0472
292 B-CELL LYMPHOMA 160 0.0471
293 WOUND DEHISCENCE 158 0.0467
294 PORTAL VEIN THROMBOSIS 150 0.0464
295 PNEUMONIA VIRAL 148 0.0464
296 END STAGE RENAL DISEASE 839 0.0460
297 BLOOD CREATININE INCREASED 2999 0.0459
298 TOXIC ENCEPHALOPATHY 230 0.0454
299 SKIN PAPILLOMA 182 0.0453
300 LEUKOPENIA 2267 0.0453
301 ENDOCARDITIS 232 0.0452
302 LYMPHOPENIA 636 0.0449
303 GUILLAIN-BARRE SYNDROME 217 0.0448
304 HYPERURICAEMIA 184 0.0447
305 HYPOALBUMINAEMIA 348 0.0447
306 RENAL IMPAIRMENT 3760 0.0447
307 PREMATURE DELIVERY 711 0.0446
308 PORTAL HYPERTENSION 136 0.0441
309 PULMONARY TUBERCULOSIS 188 0.0440
310 NOSOCOMIAL INFECTION 96 0.0435
311 HYPERAMMONAEMIA 217 0.0433
312 CLOSTRIDIAL INFECTION 146 0.0431
313 BACTERIAL INFECTION 795 0.0426
314 STEM CELL TRANSPLANT 106 0.0424
315 DRUG LEVEL BELOW THERAPEUTIC 234 0.0424
316 BLOOD IMMUNOGLOBULIN G DECREASED 105 0.0423
317 TUBULOINTERSTITIAL NEPHRITIS 793 0.0423
318 LUNG OPACITY 109 0.0413
319 TRANSPLANT 98 0.0412
320 ACUTE KIDNEY INJURY 6303 0.0411
321 DRUG INTERACTION 6513 0.0410
322 LEFT VENTRICULAR HYPERTROPHY 175 0.0408
323 POTENTIATING DRUG INTERACTION 137 0.0408
324 DERMATOMYOSITIS 103 0.0406
325 ANURIA 349 0.0405
326 BLOOD CREATINE INCREASED 179 0.0404
327 HEPATOCELLULAR CARCINOMA 307 0.0403
328 DYSLIPIDAEMIA 204 0.0401
329 NEPHROGENIC ANAEMIA 186 0.0401
330 RESPIRATORY FAILURE 2914 0.0399
331 FOETAL GROWTH RESTRICTION 242 0.0398
332 ENCEPHALOPATHY 972 0.0395
333 CUSHINGOID 127 0.0395
334 NECROSIS 220 0.0395
335 HAEMOLYTIC ANAEMIA 353 0.0394
336 ENDOPHTHALMITIS 235 0.0391
337 SERUM SICKNESS 109 0.0391
338 ENTEROCOLITIS 225 0.0389
339 DISSEMINATED INTRAVASCULAR COAGULATION 548 0.0389
340 HEPATITIS B 234 0.0388
341 HAEMODYNAMIC INSTABILITY 289 0.0379
342 PANCYTOPENIA 2114 0.0378
343 MULTI-ORGAN FAILURE 643 0.0372
344 METABOLIC ENCEPHALOPATHY 110 0.0366
345 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 140 0.0366
346 DRUG RESISTANCE 941 0.0366
347 NORMOCHROMIC NORMOCYTIC ANAEMIA 109 0.0362
348 STAPHYLOCOCCAL INFECTION 1191 0.0361
349 AZOTAEMIA 144 0.0360
350 HEPATITIS B REACTIVATION 114 0.0359
351 IMMUNOSUPPRESSION 316 0.0358
352 HYPERKALAEMIA 1251 0.0356
353 HAEMODIALYSIS 297 0.0353
354 NEPHROPATHY 330 0.0353
355 LUNG TRANSPLANT 124 0.0350
356 CYTOPENIA 427 0.0348
357 ACUTE RESPIRATORY FAILURE 666 0.0346
358 NEPHRITIS 115 0.0344
359 HYPERVOLAEMIA 170 0.0344
360 HEPATITIS CHOLESTATIC 207 0.0343
361 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 302 0.0341
362 RENAL CELL CARCINOMA 166 0.0339
363 FIBROSIS 104 0.0338
364 LUNG ADENOCARCINOMA 101 0.0335
365 ENTERITIS 214 0.0334
366 SPLENOMEGALY 385 0.0328
367 FUNGAL INFECTION 1094 0.0328
368 POSTOPERATIVE WOUND INFECTION 221 0.0327
369 DUODENITIS 100 0.0326
370 SEPSIS 3633 0.0325
371 ASCITES 957 0.0325
372 HYPOMAGNESAEMIA 453 0.0325
373 PROSTATITIS 99 0.0325
374 ARTHRITIS BACTERIAL 132 0.0321
375 FOOD ALLERGY 247 0.0320
376 URINE OUTPUT DECREASED 277 0.0317
377 GASTROINTESTINAL TOXICITY 152 0.0316
378 SKIN NECROSIS 161 0.0310
379 FAILURE TO THRIVE 161 0.0310
380 RESPIRATORY SYNCYTIAL VIRUS INFECTION 270 0.0310
381 CHRONIC MYELOID LEUKAEMIA 142 0.0307
382 HYPERTRIGLYCERIDAEMIA 180 0.0307
383 PREMATURE BABY 923 0.0306
384 HAEMOLYSIS 234 0.0303
385 ABDOMINAL ABSCESS 133 0.0301
386 PROTEIN URINE PRESENT 150 0.0301
387 SUBCUTANEOUS ABSCESS 144 0.0300
388 RENAL FAILURE CHRONIC 231 0.0300
389 IMMUNE THROMBOCYTOPENIA 137 0.0299
390 HEART DISEASE CONGENITAL 104 0.0294
391 HERPES VIRUS INFECTION 169 0.0293
392 ODYNOPHAGIA 173 0.0290
393 LARGE INTESTINE PERFORATION 200 0.0288
394 GASTROENTERITIS 420 0.0288
395 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1573 0.0286
396 MYOPATHY 247 0.0286
397 PULMONARY HAEMORRHAGE 220 0.0281
398 CORONAVIRUS INFECTION 185 0.0279
399 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 181 0.0278
400 HEPATIC FAILURE 839 0.0278
401 ELECTROLYTE IMBALANCE 323 0.0278
402 BRAIN OEDEMA 350 0.0277
403 ATELECTASIS 266 0.0275
404 ACIDOSIS 210 0.0275
405 BLOOD UREA INCREASED 459 0.0274
406 THERAPY PARTIAL RESPONDER 426 0.0273
407 INTRACRANIAL PRESSURE INCREASED 152 0.0272
408 BONE MARROW FAILURE 554 0.0272
409 CANDIDIASIS 109 0.0271
410 HYPOVOLAEMIA 159 0.0271
411 DEVICE RELATED INFECTION 418 0.0271
412 CATATONIA 141 0.0268
413 LUNG INFILTRATION 237 0.0268
414 BASAL CELL CARCINOMA 415 0.0266
415 VIRAL LOAD INCREASED 103 0.0265
416 CHOLESTASIS 505 0.0263
417 BRONCHIECTASIS 177 0.0262
418 PRODUCT USE IN UNAPPROVED INDICATION 6480 0.0261
419 PULMONARY MASS 389 0.0261
420 CARDIAC TAMPONADE 124 0.0261
421 CLOSTRIDIUM DIFFICILE INFECTION 569 0.0260
422 DISEASE RECURRENCE 1240 0.0260
423 NEUROLOGICAL SYMPTOM 149 0.0260
424 HYPERCALCAEMIA 320 0.0259
425 ABSCESS LIMB 109 0.0256
426 METASTASES TO LYMPH NODES 170 0.0252
427 SKIN MASS 168 0.0251
428 HYPERBILIRUBINAEMIA 260 0.0251
429 MENINGITIS 167 0.0250
430 PERICARDIAL EFFUSION 576 0.0249
431 MYASTHENIA GRAVIS 200 0.0247
432 METABOLIC ACIDOSIS 787 0.0246
433 HYDROCEPHALUS 133 0.0244
434 PULSELESS ELECTRICAL ACTIVITY 100 0.0239
435 CACHEXIA 122 0.0237
436 TOXICITY TO VARIOUS AGENTS 3985 0.0236
437 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 242 0.0235
438 MUCOSAL INFLAMMATION 611 0.0233
439 AUTOIMMUNE HEPATITIS 162 0.0233
440 DIALYSIS 330 0.0232
441 AGRANULOCYTOSIS 431 0.0232
442 PLEURAL EFFUSION 1409 0.0231
443 GLOMERULAR FILTRATION RATE DECREASED 283 0.0230
444 PAPULE 162 0.0230
445 COVID-19 4007 0.0228
446 MALNUTRITION 255 0.0228
447 ACUTE MYELOID LEUKAEMIA 353 0.0226
448 SKIN INFECTION 254 0.0226
449 INFLAMMATORY MARKER INCREASED 112 0.0226
450 ACUTE HEPATIC FAILURE 308 0.0225
451 IRON DEFICIENCY ANAEMIA 208 0.0225
452 BLOOD LACTATE DEHYDROGENASE INCREASED 357 0.0225
453 STREPTOCOCCAL INFECTION 125 0.0224
454 RESPIRATORY DISTRESS 618 0.0224
455 RENAL FAILURE 2964 0.0223
456 WOUND INFECTION 244 0.0223
457 ILEUS PARALYTIC 99 0.0222
458 VASCULAR DEVICE INFECTION 100 0.0220
459 SUBARACHNOID HAEMORRHAGE 224 0.0220
460 BLOOD ALBUMIN DECREASED 173 0.0218
461 MENTAL STATUS CHANGES 603 0.0217
462 HYPOVOLAEMIC SHOCK 103 0.0215
463 SKIN LESION 587 0.0214
464 METASTASES TO LUNG 247 0.0214
465 ARTERIOSCLEROSIS 201 0.0213
466 INTESTINAL ISCHAEMIA 117 0.0212
467 SERUM FERRITIN INCREASED 112 0.0212
468 HYPERGLYCAEMIA 773 0.0212
469 INTERSTITIAL LUNG DISEASE 1026 0.0212
470 LUNG INFECTION 328 0.0211
471 HYPOPHOSPHATAEMIA 156 0.0211
472 PREMATURE LABOUR 119 0.0210
473 FEBRILE NEUTROPENIA 1396 0.0210
474 PANCREATITIS ACUTE 472 0.0210
475 STATUS EPILEPTICUS 236 0.0209
476 SHOCK 479 0.0208
477 CARDIAC FAILURE ACUTE 138 0.0207
478 COLITIS 783 0.0206
479 BLOOD MAGNESIUM DECREASED 178 0.0206
480 PNEUMOTHORAX 327 0.0206
481 PERITONITIS 426 0.0205
482 DIABETES MELLITUS 1561 0.0205
483 GESTATIONAL DIABETES 97 0.0203
484 OSTEOMYELITIS 367 0.0202
485 OESOPHAGITIS 221 0.0202
486 RENAL FAILURE ACUTE 857 0.0202
487 INFLAMMATORY BOWEL DISEASE 196 0.0200
488 MOUTH ULCERATION 421 0.0200
489 THROMBOCYTOPENIA 2231 0.0199
490 LEUKOCYTOSIS 360 0.0199
491 SKIN PLAQUE 167 0.0198
492 MYOSITIS 177 0.0197
493 DERMATITIS ATOPIC 1039 0.0197
494 HYPERLIPIDAEMIA 235 0.0196
495 BLOOD POTASSIUM INCREASED 318 0.0196
496 ANGIOPATHY 109 0.0194
497 TRANSAMINASES INCREASED 428 0.0192
498 COAGULOPATHY 317 0.0190
499 GASTRIC ULCER 361 0.0190
500 NEUTROPENIA 2572 0.0189
501 NEUTROPENIC SEPSIS 135 0.0189
502 VENTRICULAR SEPTAL DEFECT 108 0.0188
503 HEPATIC FUNCTION ABNORMAL 701 0.0188
504 MALABSORPTION 98 0.0187
505 NORMAL NEWBORN 102 0.0187
506 HEPATIC ENCEPHALOPATHY 175 0.0187
507 DIABETIC KETOACIDOSIS 448 0.0186
508 RALES 108 0.0186
509 PLEURISY 110 0.0185
510 DIARRHOEA HAEMORRHAGIC 173 0.0185
511 SMALL INTESTINAL OBSTRUCTION 227 0.0184
512 THERAPY NON-RESPONDER 828 0.0184
513 HAEMORRHAGE INTRACRANIAL 271 0.0181
514 OFF LABEL USE 15788 0.0180
515 PULMONARY TOXICITY 127 0.0179
516 RENAL DISORDER 831 0.0178
517 METASTASIS 127 0.0178
518 HYPOXIA 619 0.0176
519 ORAL CANDIDIASIS 231 0.0175
520 CHRONIC KIDNEY DISEASE 1326 0.0174
521 RESPIRATORY TRACT INFECTION 454 0.0174
522 VIRAL INFECTION 579 0.0174
523 INTESTINAL PERFORATION 195 0.0174
524 LYMPHOMA 268 0.0173
525 DUODENAL ULCER 122 0.0173
526 TYPE 1 DIABETES MELLITUS 104 0.0172
527 HYPERTRANSAMINASAEMIA 120 0.0172
528 ILEUS 214 0.0172
529 LIVER FUNCTION TEST ABNORMAL 498 0.0171
530 GENERALISED TONIC-CLONIC SEIZURE 282 0.0170
531 INFECTION 2439 0.0168
532 LYMPHADENOPATHY 593 0.0167
533 GLUCOSE TOLERANCE IMPAIRED 98 0.0166
534 PHOTOSENSITIVITY REACTION 273 0.0165
535 EXPOSURE DURING PREGNANCY 1021 0.0164
536 RETINAL HAEMORRHAGE 117 0.0164
537 BLOOD URIC ACID INCREASED 94 0.0163
538 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 276 0.0162
539 ANAEMIA 3076 0.0161
540 GASTROINTESTINAL INFECTION 144 0.0160
541 REBOUND EFFECT 179 0.0158
542 HEPATIC CIRRHOSIS 296 0.0157
543 ABSCESS 251 0.0157
544 FLUID OVERLOAD 228 0.0157
545 TUMOUR LYSIS SYNDROME 137 0.0156
546 URINARY TRACT INFECTION 2651 0.0155
547 CARDIOGENIC SHOCK 222 0.0155
548 BLOOD BILIRUBIN INCREASED 415 0.0153
549 MYELODYSPLASTIC SYNDROME 222 0.0153
550 LYMPHOCYTE COUNT DECREASED 269 0.0152
551 HEPATOMEGALY 149 0.0151
552 HERPES ZOSTER 871 0.0151
553 CEREBRAL INFARCTION 369 0.0151
554 PERITONITIS BACTERIAL 152 0.0150
555 NEUTROPHIL COUNT INCREASED 154 0.0150
556 GENERALISED OEDEMA 186 0.0150
557 POLYURIA 123 0.0150
558 APHTHOUS ULCER 115 0.0148
559 HEPATOTOXICITY 329 0.0148
560 ORAL DISORDER 107 0.0146
561 HAEMATURIA 499 0.0146
562 HEMIPARESIS 246 0.0145
563 PNEUMONIA 4683 0.0145
564 PYREXIA 4949 0.0143
565 HAEMATOCRIT DECREASED 283 0.0143
566 SKIN CANCER 306 0.0142
567 TACHYPNOEA 193 0.0142
568 ADRENAL INSUFFICIENCY 171 0.0141
569 ECZEMA 731 0.0140
570 TREATMENT FAILURE 1155 0.0139
571 MATERNAL EXPOSURE DURING PREGNANCY 1242 0.0139
572 PNEUMONITIS 378 0.0139
573 MITRAL VALVE INCOMPETENCE 155 0.0137
574 RENAL CYST 108 0.0136
575 SKIN ULCER 351 0.0136
576 SPINAL COMPRESSION FRACTURE 112 0.0135
577 DRUG TOXICITY 184 0.0135
578 C-REACTIVE PROTEIN INCREASED 489 0.0134
579 ALTERED STATE OF CONSCIOUSNESS 287 0.0132
580 BLOOD ALKALINE PHOSPHATASE INCREASED 328 0.0132
581 VISUAL FIELD DEFECT 95 0.0131
582 MALIGNANT MELANOMA 176 0.0131
583 CENTRAL NERVOUS SYSTEM LESION 180 0.0131
584 SKIN HYPERPIGMENTATION 112 0.0130
585 MYOCLONUS 155 0.0130
586 CEREBRAL HAEMORRHAGE 465 0.0130
587 PULMONARY HYPERTENSION 270 0.0129
588 POST PROCEDURAL COMPLICATION 248 0.0129
589 MYOCARDITIS 148 0.0129
590 ORAL HERPES 252 0.0129
591 FACIAL PARALYSIS 110 0.0129
592 FOETAL EXPOSURE DURING PREGNANCY 1048 0.0129
593 TREATMENT NONCOMPLIANCE 701 0.0128
594 ABORTION INDUCED 120 0.0127
595 VASCULITIS 148 0.0127
596 CELLULITIS 637 0.0126
597 HYPONATRAEMIA 712 0.0126
598 PNEUMONIA ASPIRATION 313 0.0125
599 HAEMATOMA 321 0.0124
600 JAUNDICE 329 0.0122
601 HAEMATOTOXICITY 116 0.0122
602 PULMONARY OEDEMA 544 0.0121
603 CARDIOMEGALY 148 0.0120
604 LIVER DISORDER 533 0.0120
605 KIDNEY INFECTION 235 0.0120
606 CARDIOMYOPATHY 175 0.0118
607 CARDIAC ARREST 971 0.0117
608 GAMMA-GLUTAMYLTRANSFERASE INCREASED 260 0.0117
609 MELAENA 257 0.0117
610 METASTASES TO LIVER 205 0.0117
611 SKIN HAEMORRHAGE 172 0.0116
612 SKIN FISSURES 226 0.0116
613 HAEMOGLOBIN DECREASED 1183 0.0115
614 HAEMOPTYSIS 320 0.0115
615 HYPERTENSION 2427 0.0114
616 MYOCARDIAL ISCHAEMIA 130 0.0114
617 HYPOCALCAEMIA 216 0.0114
618 COLITIS ULCERATIVE 506 0.0113
619 ULCER 180 0.0113
620 ATAXIA 134 0.0113
621 DERMATITIS 235 0.0112
622 HEPATITIS 286 0.0112
623 IMMUNE SYSTEM DISORDER 147 0.0111
624 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 325 0.0111
625 CAESAREAN SECTION 129 0.0111
626 IMMUNODEFICIENCY 163 0.0109
627 ALANINE AMINOTRANSFERASE INCREASED 671 0.0109
628 ABORTION SPONTANEOUS 437 0.0109
629 MASS 152 0.0109
630 SUPRAVENTRICULAR TACHYCARDIA 104 0.0109
631 DRUG-INDUCED LIVER INJURY 340 0.0108
632 TREMOR 1795 0.0108
633 INTRAOCULAR PRESSURE INCREASED 138 0.0108
634 INTENTIONAL PRODUCT USE ISSUE 942 0.0107
635 HEPATIC STEATOSIS 200 0.0107
636 UPPER RESPIRATORY TRACT INFECTION 496 0.0107
637 CONDITION AGGRAVATED 3249 0.0107
638 NO THERAPEUTIC RESPONSE 130 0.0107
639 EOSINOPHILIA 186 0.0106
640 APPENDICITIS 99 0.0106
641 CIRCULATORY COLLAPSE 178 0.0104
642 GASTRITIS 274 0.0104
643 UVEITIS 141 0.0104
644 RENAL INJURY 307 0.0103
645 CHOLECYSTITIS 123 0.0103
646 MYELOSUPPRESSION 369 0.0102
647 CONJUNCTIVITIS 190 0.0102
648 GASTROINTESTINAL HAEMORRHAGE 853 0.0102
649 OSTEONECROSIS 335 0.0102
650 PREGNANCY 204 0.0102
651 HEPATOCELLULAR INJURY 144 0.0101
652 ASPARTATE AMINOTRANSFERASE INCREASED 538 0.0101
653 DISEASE PROGRESSION 1197 0.0101
654 DELIRIUM 351 0.0101
655 ANOREXIA 130 0.0101
656 HYPERCHOLESTEROLAEMIA 97 0.0100
657 GASTROINTESTINAL DISORDER 893 0.0100
658 FISTULA 112 0.0100
659 RESPIRATORY DISORDER 298 0.0100
660 CARDIAC FAILURE 799 0.0099
661 GOUT 174 0.0097
662 OEDEMA 525 0.0097
663 METASTASES TO BONE 158 0.0096
664 VENTRICULAR FIBRILLATION 106 0.0095
665 NERVOUS SYSTEM DISORDER 297 0.0095
666 DYSURIA 349 0.0095
667 CYTOKINE RELEASE SYNDROME 190 0.0095
668 HYPOPHAGIA 241 0.0094
669 PRODUCT PRESCRIBING ISSUE 205 0.0094
670 TENDERNESS 98 0.0094
671 DIARRHOEA 6064 0.0094
672 INFLAMMATION 484 0.0094
673 APHASIA 283 0.0094
674 OBSTRUCTIVE AIRWAYS DISORDER 104 0.0093
675 LUNG DISORDER 458 0.0093
676 HEPATIC CYTOLYSIS 119 0.0093
677 PULMONARY FIBROSIS 177 0.0092
678 RASH MACULO-PAPULAR 205 0.0092
679 DRUG INTOLERANCE 887 0.0092
680 DEHYDRATION 1217 0.0091
681 IMPAIRED HEALING 297 0.0090
682 LIVER FUNCTION TEST INCREASED 194 0.0090
683 THERAPEUTIC RESPONSE DECREASED 547 0.0090
684 ASPIRATION 98 0.0089
685 LACTIC ACIDOSIS 289 0.0089
686 VENTRICULAR TACHYCARDIA 147 0.0089
687 PLATELET COUNT DECREASED 946 0.0089
688 ELECTROCARDIOGRAM QT PROLONGED 315 0.0087
689 COMA 417 0.0087
690 SCAB 99 0.0087
691 DEEP VEIN THROMBOSIS 562 0.0086
692 UPPER GASTROINTESTINAL HAEMORRHAGE 145 0.0086
693 BLOOD TRIGLYCERIDES INCREASED 152 0.0086
694 HEPATIC ENZYME INCREASED 586 0.0086
695 ISCHAEMIC STROKE 153 0.0086
696 LIVER INJURY 210 0.0085
697 DIVERTICULITIS 236 0.0085
698 ABDOMINAL PAIN 1978 0.0085
699 RED BLOOD CELL COUNT DECREASED 243 0.0085
700 PHARYNGITIS 105 0.0085
701 STOMATITIS 513 0.0085
702 PRODUCT USE ISSUE 1579 0.0084
703 IMPAIRED GASTRIC EMPTYING 114 0.0084
704 PULMONARY CONGESTION 110 0.0083
705 NODULE 108 0.0083
706 DEPRESSED LEVEL OF CONSCIOUSNESS 327 0.0083
707 SINUS TACHYCARDIA 117 0.0082
708 WHITE BLOOD CELL COUNT INCREASED 316 0.0082
709 BLOOD SODIUM DECREASED 155 0.0082
710 PANCREATITIS 434 0.0082
711 POST PROCEDURAL HAEMORRHAGE 95 0.0082
712 HAEMORRHOIDS 159 0.0081
713 HOSPITALISATION 1251 0.0081
714 CYSTITIS 258 0.0081
715 DRUG INEFFECTIVE 10578 0.0080
716 DIPLOPIA 207 0.0080
717 ACUTE MYOCARDIAL INFARCTION 234 0.0079
718 POLYNEUROPATHY 95 0.0079
719 GASTROENTERITIS VIRAL 143 0.0079
720 SUBDURAL HAEMATOMA 113 0.0079
721 HALLUCINATION, VISUAL 166 0.0079
722 TACHYCARDIA 693 0.0078
723 PARALYSIS 111 0.0077
724 OSTEOPENIA 117 0.0077
725 PRODUCTIVE COUGH 368 0.0077
726 EPILEPSY 235 0.0077
727 PERICARDITIS 129 0.0077
728 SKIN EXFOLIATION 647 0.0077
729 MUSCLE ATROPHY 97 0.0076
730 HYPOKALAEMIA 352 0.0076
731 CONVULSION 434 0.0076
732 OEDEMA PERIPHERAL 921 0.0075
733 OSTEOPOROSIS 310 0.0075
734 INTESTINAL OBSTRUCTION 283 0.0075
735 ACNE 568 0.0075
736 COLON CANCER 111 0.0074
737 DYSPNOEA EXERTIONAL 280 0.0074
738 TOXIC EPIDERMAL NECROLYSIS 112 0.0074
739 GENERAL PHYSICAL HEALTH DETERIORATION 852 0.0074
740 DRUG EXPOSURE DURING PREGNANCY 250 0.0073
741 CARDIO-RESPIRATORY ARREST 305 0.0073
742 PSYCHOTIC DISORDER 215 0.0073
743 SYSTEMIC LUPUS ERYTHEMATOSUS 257 0.0072
744 ATRIAL FIBRILLATION 702 0.0072
745 VISUAL ACUITY REDUCED 237 0.0071
746 HYPOTHYROIDISM 226 0.0071
747 INFLUENZA 785 0.0070
748 PULMONARY EMBOLISM 668 0.0070
749 BLOOD PRESSURE SYSTOLIC INCREASED 137 0.0070
750 HYPOTENSION 1395 0.0069
751 BLINDNESS 278 0.0068
752 SEIZURE 787 0.0068
753 CORONARY ARTERY DISEASE 206 0.0068
754 DYSARTHRIA 253 0.0067
755 NEOPLASM MALIGNANT 446 0.0067
756 HAEMATOCHEZIA 368 0.0067
757 DRUG ERUPTION 118 0.0067
758 VOMITING 3091 0.0066
759 PRESCRIBED UNDERDOSE 131 0.0066
760 THROMBOSIS 528 0.0066
761 WHITE BLOOD CELL COUNT DECREASED 711 0.0066
762 BODY TEMPERATURE INCREASED 133 0.0065
763 DRY EYE 325 0.0065
764 DIABETES MELLITUS INADEQUATE CONTROL 114 0.0064
765 RASH ERYTHEMATOUS 307 0.0064
766 RHABDOMYOLYSIS 267 0.0064
767 URINARY RETENTION 212 0.0063
768 CHILLS 742 0.0063
769 LOCALISED INFECTION 152 0.0063
770 ABDOMINAL PAIN LOWER 158 0.0062
771 FLUID RETENTION 317 0.0062
772 WEIGHT DECREASED 1735 0.0062
773 DRY SKIN 828 0.0062
774 LABORATORY TEST ABNORMAL 183 0.0062
775 DISCOMFORT 377 0.0062
776 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 439 0.0062
777 PHOTOPHOBIA 116 0.0062
778 DRUG DISPENSING ERROR 94 0.0061
779 UNRESPONSIVE TO STIMULI 154 0.0060
780 DISORIENTATION 236 0.0059
781 DEATH 5120 0.0059
782 SKIN DISORDER 197 0.0059
783 CONFUSIONAL STATE 954 0.0059
784 DYSPHAGIA 551 0.0058
785 PRODUCT PRESCRIBING ERROR 138 0.0058
786 BLOOD PRESSURE FLUCTUATION 139 0.0058
787 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 99 0.0058
788 SCAR 98 0.0057
789 HAEMORRHAGE 598 0.0057
790 CHOLELITHIASIS 187 0.0057
791 NEUTROPHIL COUNT DECREASED 232 0.0057
792 NEPHROLITHIASIS 259 0.0056
793 COUGH 1581 0.0056
794 LOWER RESPIRATORY TRACT INFECTION 256 0.0056
795 OXYGEN SATURATION DECREASED 316 0.0056
796 RASH PAPULAR 125 0.0056
797 ALOPECIA 1093 0.0056
798 DECREASED APPETITE 1292 0.0056
799 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 266 0.0055
800 PRURITUS 2108 0.0055
801 PLASMA CELL MYELOMA 214 0.0055
802 HAEMATEMESIS 139 0.0055
803 CATARACT 323 0.0054
804 RESTLESS LEGS SYNDROME 97 0.0053
805 TYPE 2 DIABETES MELLITUS 178 0.0053
806 NEUROPATHY PERIPHERAL 501 0.0053
807 GLYCOSYLATED HAEMOGLOBIN INCREASED 132 0.0052
808 FRACTURE 99 0.0052
809 INTERNATIONAL NORMALISED RATIO INCREASED 149 0.0052
810 BRADYCARDIA 277 0.0052
811 THERAPEUTIC RESPONSE SHORTENED 173 0.0052
812 ANAPHYLACTIC REACTION 286 0.0052
813 EYE PAIN 292 0.0052
814 RASH 2255 0.0052
815 EYE PRURITUS 173 0.0051
816 MUSCULAR WEAKNESS 578 0.0051
817 SLEEP APNOEA SYNDROME 97 0.0051
818 SURGERY 297 0.0051
819 RASH MACULAR 177 0.0051
820 HYPOGLYCAEMIA 243 0.0050
821 ERYTHEMA 1029 0.0050
822 BRONCHITIS 370 0.0050
823 NIGHT SWEATS 160 0.0050
824 LUNG NEOPLASM MALIGNANT 204 0.0050
825 ACCIDENTAL OVERDOSE 178 0.0049
826 ANGINA PECTORIS 139 0.0048
827 CARDIOVASCULAR DISORDER 123 0.0048
828 LETHARGY 272 0.0047
829 RESPIRATORY ARREST 130 0.0047
830 SLEEP DISORDER 332 0.0047
831 ASTHENIA 1742 0.0046
832 BLOOD PRESSURE INCREASED 701 0.0046
833 ABDOMINAL DISTENSION 478 0.0046
834 ARRHYTHMIA 216 0.0046
835 OCULAR HYPERAEMIA 216 0.0045
836 DYSPNOEA 2565 0.0045
837 LIMB INJURY 123 0.0045
838 SINUSITIS 460 0.0045
839 RASH PRURITIC 243 0.0045
840 EYE DISORDER 147 0.0045
841 BLOOD POTASSIUM DECREASED 134 0.0045
842 GASTROOESOPHAGEAL REFLUX DISEASE 354 0.0044
843 CARDIAC FAILURE CONGESTIVE 350 0.0044
844 EYE IRRITATION 249 0.0043
845 BLOOD PRESSURE DECREASED 287 0.0043
846 BLOOD CREATINE PHOSPHOKINASE INCREASED 123 0.0043
847 SKIN DISCOLOURATION 196 0.0043
848 NAUSEA 3375 0.0043
849 HEADACHE 2645 0.0042
850 SWELLING 394 0.0042
851 PRODUCT AVAILABILITY ISSUE 95 0.0042
852 ANGIOEDEMA 183 0.0041
853 MENTAL DISORDER 178 0.0041
854 COGNITIVE DISORDER 188 0.0040
855 ABDOMINAL PAIN UPPER 828 0.0040
856 EAR INFECTION 106 0.0040
857 CHEST PAIN 736 0.0040
858 MYALGIA 674 0.0040
859 SWELLING FACE 258 0.0040
860 PRODUCT DOSE OMISSION IN ERROR 112 0.0040
861 NEURALGIA 96 0.0039
862 PALLOR 107 0.0039
863 WEIGHT INCREASED 869 0.0039
864 VISUAL IMPAIRMENT 477 0.0038
865 WOUND 107 0.0038
866 AMNESIA 247 0.0038
867 BLISTER 213 0.0038
868 URINARY INCONTINENCE 112 0.0038
869 THERAPY INTERRUPTED 270 0.0038
870 VERTIGO 230 0.0038
871 BLOOD GLUCOSE INCREASED 707 0.0037
872 ABDOMINAL DISCOMFORT 627 0.0037
873 BLOOD CHOLESTEROL INCREASED 173 0.0037
874 GASTRIC CANCER 94 0.0037
875 MALAISE 1599 0.0036
876 OROPHARYNGEAL PAIN 337 0.0036
877 AGITATION 267 0.0036
878 VISION BLURRED 492 0.0036
879 PAIN OF SKIN 96 0.0036
880 FEMUR FRACTURE 110 0.0035
881 RHEUMATOID ARTHRITIS 402 0.0035
882 OVERDOSE 763 0.0035
883 POLLAKIURIA 146 0.0035
884 INFUSION RELATED REACTION 232 0.0035
885 CEREBROVASCULAR ACCIDENT 591 0.0035
886 PERIPHERAL SWELLING 536 0.0035
887 TRANSIENT ISCHAEMIC ATTACK 117 0.0035
888 DYSPEPSIA 339 0.0034
889 RESTLESSNESS 126 0.0034
890 MEDICATION ERROR 191 0.0034
891 EPISTAXIS 255 0.0034
892 RHINORRHOEA 220 0.0034
893 PSORIASIS 440 0.0034
894 LOSS OF CONSCIOUSNESS 429 0.0033
895 HEART RATE INCREASED 330 0.0033
896 THERAPY CESSATION 170 0.0033
897 BURNING SENSATION 229 0.0033
898 FATIGUE 2530 0.0032
899 RECTAL HAEMORRHAGE 139 0.0032
900 MOVEMENT DISORDER 102 0.0032
901 BACK PAIN 736 0.0032
902 NASOPHARYNGITIS 582 0.0032
903 CONTUSION 301 0.0031
904 GAIT DISTURBANCE 597 0.0031
905 HALLUCINATION 234 0.0031
906 ARTHRALGIA 1272 0.0031
907 SPEECH DISORDER 160 0.0031
908 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 547 0.0030
909 BONE PAIN 177 0.0030
910 CARDIAC DISORDER 282 0.0030
911 MYOCARDIAL INFARCTION 515 0.0029
912 CONSTIPATION 640 0.0029
913 ADVERSE DRUG REACTION 260 0.0029
914 SKIN IRRITATION 132 0.0029
915 GAIT INABILITY 96 0.0029
916 INSOMNIA 763 0.0029
917 THERAPEUTIC PRODUCT EFFECT DECREASED 128 0.0029
918 GASTRIC DISORDER 98 0.0029
919 LIP SWELLING 95 0.0028
920 PRODUCT DOSE OMISSION ISSUE 836 0.0028
921 FALL 946 0.0028
922 ARTHRITIS 222 0.0028
923 NEOPLASM PROGRESSION 98 0.0028
924 MUSCULOSKELETAL PAIN 147 0.0028
925 PAIN 1720 0.0028
926 PRODUCT SUBSTITUTION ISSUE 161 0.0028
927 OSTEOARTHRITIS 118 0.0028
928 CHEST DISCOMFORT 284 0.0028
929 SYNCOPE 276 0.0028
930 NASAL CONGESTION 162 0.0028
931 PAIN IN EXTREMITY 809 0.0027
932 DEPRESSED MOOD 144 0.0027
933 EYE SWELLING 101 0.0027
934 DEPRESSION 612 0.0027
935 UNEVALUABLE EVENT 202 0.0027
936 URTICARIA 440 0.0026
937 ILLNESS 270 0.0026
938 DYSKINESIA 106 0.0026
939 INTENTIONAL PRODUCT MISUSE 228 0.0026
940 HYPOAESTHESIA 386 0.0026
941 ASTHMA 290 0.0026
942 ILL-DEFINED DISORDER 154 0.0025
943 PARAESTHESIA 398 0.0025
944 AGGRESSION 126 0.0025
945 MEMORY IMPAIRMENT 345 0.0025
946 PALPITATIONS 293 0.0025
947 SOMNOLENCE 496 0.0025
948 MUSCULOSKELETAL STIFFNESS 214 0.0024
949 MIGRAINE 227 0.0024
950 MUSCLE SPASMS 426 0.0023
951 DIZZINESS 1150 0.0023
952 ROAD TRAFFIC ACCIDENT 96 0.0023
953 INCORRECT DOSE ADMINISTERED 523 0.0023
954 ANXIETY 648 0.0023
955 DRY MOUTH 184 0.0023
956 INFLUENZA LIKE ILLNESS 185 0.0022
957 BALANCE DISORDER 193 0.0022
958 DYSPHONIA 130 0.0022
959 BLOOD GLUCOSE DECREASED 106 0.0022
960 DISTURBANCE IN ATTENTION 119 0.0022
961 SKIN BURNING SENSATION 158 0.0022
962 FLATULENCE 125 0.0022
963 WHEEZING 130 0.0022
964 TINNITUS 100 0.0022
965 HYPERSENSITIVITY 404 0.0022
966 THERAPEUTIC RESPONSE UNEXPECTED 97 0.0022
967 FEELING HOT 132 0.0022
968 IRRITABILITY 127 0.0021
969 MALIGNANT NEOPLASM PROGRESSION 215 0.0021
970 HYPERHIDROSIS 263 0.0020
971 MOBILITY DECREASED 146 0.0020
972 DYSGEUSIA 145 0.0019
973 NO ADVERSE EVENT 349 0.0019
974 JOINT SWELLING 231 0.0019
975 NECK PAIN 106 0.0019
976 INJURY 128 0.0018
977 PRODUCT DOSE OMISSION 118 0.0018
978 INJECTION SITE SWELLING 136 0.0018
979 ARTHROPATHY 96 0.0017
980 ADVERSE EVENT 159 0.0017
981 FEELING ABNORMAL 395 0.0016
982 INJECTION SITE PAIN 491 0.0016
983 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 109 0.0015
984 PROSTATE CANCER 118 0.0015
985 SUICIDAL IDEATION 133 0.0015
986 FLUSHING 146 0.0014
987 EMOTIONAL DISTRESS 165 0.0014
988 ACCIDENTAL EXPOSURE TO PRODUCT 136 0.0013
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 232 0.0011
990 DRUG DOSE OMISSION 188 0.0011
991 INJECTION SITE ERYTHEMA 129 0.0010
992 PRODUCT QUALITY ISSUE 140 0.0010